Recent developments in the field of molecular biology have increased our understanding of the molecular features of malignant mesothelioma (MM). This knowledge, together with the development of sensitive and high throughput molecular techniques, has helped to identify biomarkers that not only facilitate early and differential diagnosis but also assist in the evaluation of the prognosis and effectiveness of the treatment provided. Similarly, these advances have also shed light on the etiology of the diseases, for example, exposures to different environmental factors. Importantly, the novel and more sensitive methods have made it possible to detect these biomarkers in body fluids like pleural effusions, plasma, serum, urine, and sputum, making them suitable for fast and early diagnosis, as well as for the follow-up of the disease without the need for tissue from the primary tumor for analysis. © Springer Nature Switzerland AG 2020.
|Titel på gästpublikation||Occupational Cancers|
|Redaktörer||Sisko Anttila, Paolo Boffetta|
|Förlag||Springer International Publishing|
|Status||Publicerad - 2020|
|MoE-publikationstyp||A3 Del av bok eller annan forskningsbok|
- 3122 Cancersjukdomar